Skip to main content
. 2024 Jun 10;13(12):3396. doi: 10.3390/jcm13123396

Table 2.

Demographics and clinical characteristics of CTR, CRh, and CI groups of trials included in the systematic review.

Study Group Subjects
[n]
Sex
[n male; female]
Age (y)
[M; SD]
LVEF
[M; SD]
VO2 [M; SD]
Avila et al., 2018 [19] CTR 30 26; 4 58.6; 13 - 26.7; 6.55
CI 30 27; 3 61.9; 7.3 - 25.4; 7.32
Avila et al., 2020 [20] CTR 26 23; 3 62.2; 7.1 - 26.7; 6.55
CI 29 23; 3 62.0; 7.4 - 25.4; 7.3
Batalik et al., 2021 [21] CRh 23 19; 4 56.1; 6.8 59.9; 5.9 23.7; 4.0
CI 25 22; 3 57.2; 7.5 58.1; 5.8 23.1; 3.0
Batalik et al., 2021a [22] CRh 28 17; 11 56.1; 6.8 60.1; 5.8 23.7; 4.0
CI 28 19; 9 57.1; 7.9 58.9; 5.5 23.0; 3.0
Batalik et al., 2020 [7] CRh 25 20; 5 56.5; 6.9 60.2; 5.6 23.7; 4.1
CI 26 22; 4 57.7; 7.6 59.2; 5.7 23.4; 3.3
Bravo-Escobar et al., 2021 [23] CRh 33 31; 2 56.18; 8.71 40–55% -
CI 38 35; 3 55.32; 7.97 40–55% -
Bravo-Escobar et al., 2017 [24] CRh 13 14; 0 56.50; 6.01 51.00; 7.9 -
CI 14 14; 0 55.64; 11.3 52.33; 3.51 -
Dale et al., 2015 [25] CRh 61 48; 13 59.0; 10.5 - -
CI 62 52; 10 59.9; 11.8 - -
De Lima et al., 2022 [26] CRh 23 19; 4 58.13; 8.94 - -
CI 26 23; 3 54.81; 11.4 - -
Dorje et al., 2019 [27] CTR 156 128; 28 59.1; 9.4 62.9; 6.4 -
CI 156 126; 30 61.9; 8.7 63.2; 6.9 -
Fang et al., 2019 [28] CTR 33 21; 12 60.24; 9.3 62.97; 6.8 -
CI 34 21; 13 61.41; 10.1 62.15; 1.16 -
Ghorbani et al., 2021 [29] CTR 37 24; 13 - - -
CI 37 19; 18 - - -
He et al., 2020 [30] CRh 37 24; 13 - - -
CI 37 19; 18 - - -
Hong et al., 2020 [31] CTR 30 23; 7 61–70 (53.4%) - -
CI 30 20; 10 41–60 (53.4%) - -
Kraal et al., 2017 [32] CRh 45 40; 5 60.5; 8.8 - 24.4; 6.7
CI 45 40; 5 57.7; 8.7 - 24.0; 5.6
Kraal et al., 2014 [33] CRh 25 22; 3 60.6; 7.5 - 22.8; 4.2
CI 25 21; 4 56.1; 8.7 - 23.7; 6.4
Lee et al., 2013 [34] CTR 26 22; 4 54.3; 8.9 55; 10 -
CI 29 22; 7 57.8; 7.5 50; 10 -
Lee et al., 2013a [35] CRh 25 18; 7 55.56; 9.23 52.48; 9.40 -
CI 25 19; 6 57.88; 7.90 62.04; 9.42 -
Maddison et al., 2015 [36] CTR 85 69; 16 61.4; 8.9 - 26.8; 6.4
CI 86 70; 16 59.0; 9.5 - 27.1; 6.5
Maddison et al., 2018 [37] CTR 82 69; 13 61.0; 13.2 - 27.22; 7.91
CI 80 70; 10 61.5; 12.2 - 27.70; 6.77
Reid et al., 2011 [38] CTR 115 95; 20 56.7; 9.0 - -
CI 108 93; 15 56.0; 9.0 - -
Shi et al., 2022 [39] CRh 25 21; 4 49.80; 7.74 - -
CI 26 19; 7 51.38; 7.54 - -
Skobel et al., 2017 [40] CRh 55 50; 5 60 (50.5%) 56 (50.65%) 21.5 (17.2; 24.8)
CI 63 55; 8 58 (52.67%) 61 (57.70%) 20 (17.23%)
Snoek et al., 2021 [41] CTR 89 20 72.4; 5.4 - 18.9; 5.4
CI 90 14 73.6; 5.5 - 20.3; 5.7
Snoek et al., 2021a [42] CTR 61 50; 11 60.0; 8.4 - 22.8; 6.0
CI 61 50; 11 59.0; 10.7 - 22.1; 4.8
Song et al., 2020 [43] CTR 48 43; 5 54.17; 8.76 63.98; 10.7 20.40; 4.57
CI 48 40; 8 54.83; 9.13 66.25; 9.06 18.83; 3.98
Su and Yu, 2021 [44] CTR 73 62; 11 55.53; 7.30 - -
CI 73 60; 13 56.03; 7.02 - -
Vieira et al., 2018 [45] CRh 11 - 55; 9.0 - -
CI 11 - 59; 11.3 - -

Legend: CI = Conventional Intervention; CRh = Cardiac Rehabilitation hybrid; CTR = Cardiac Telerehabilitation; LVEF = Left Ventricular Ejection Fraction. M = mean; SD = Standard Deviation; VO2 = max Oxygen Consumption; y = years.